Insulet (Nasdaq:PODD) announced today that it received FDA 510(k) clearance for new enhancements to its Omnipod 5 system.

MannKind (Nasdaq:MNKD) announced that the FDA accepted a supplemental New Drug Application (sNDA) for its Furoscix ReadyFlow ...

Insulet (Nasdaq:PODD) today announced immediate compatibility between its Omnipod 5 system and the Dexcom (Nasdaq:DXCM) G7 15 ...

Medtronic (NYSE:MDT) announced the full U.S. launch for its Instinct sensor, made by Abbott, paired with the MiniMed 780G ...

Ripple Therapeutics announced today that it entered into a deal with a Bausch + Lomb affiliate related to drug delivery ...

Embecta (Nasdaq:EMBC) today posted fourth-quarter financial results that proved mixed compared to the consensus forecast on ...

PreEvnt aims for Isaac to help people with type 1, type 2 and pre-diabetes, reducing the need for or frequency of ...

Abbott (NYSE:ABT) announced today that it issued a device correction for certain FreeStyle Libre 3 and Libre 3 Plus sensors ...

Insulet (Nasdaq:PODD) today revealed plans for its innovation pipeline, which includes the next-generation Omnipod 6 system.